10. Bibliografia

-Ahluwalia J, Fabi SG. The psychological and aesthetic impact of age-related hair changes in females. J Cosmet Dermatol. 2019. doi: 10.1111/jocd.12960.

-Fernandez-Flores A, Saeb-Lima M, Cassarino DS. Histopathology of aging of the hair follicle. J Cutan Pathol. 2019. doi: 10.1111/cup.13467.

-Piraccini BM, Alessandrini A. Androgenetic alopecia. G Ital Dermatol Venereol. 2014; 149:15-24.

-Lolli F, Pallotti F, Rossi A, Fortuna MC, Caro G, Lenzi A, Sansone A, Lombardo F. Androgenetic alopecia: a review. Endocrine. 2017; 57:9-17.

-Dhariwala MY, Ravikumar P. An overview of herbal alternatives in androgenetic alopecia. J Cosmet Dermatol. 2019. doi: 10.1111/jocd.12930.

-Sharma A, Goren A, Dhurat R, Agrawal S, Sinclair R, Trüeb RM, Vañó-Galván S, Chen G, Tan Y, Kovacevic M, Situm M, McCoy J. Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes. Dermatol Ther. 2019:e12915.

-Motofei IG, Rowland DL, Tampa M, Sarbu MI, Mitran MI, Mitran CI, Stoian AP, Diaconu CC, Paunica S, Georgescu SR. Finasteride and androgenic alopecia; from therapeutic options to medical implications. J Dermatolog Treat. 2019 21:1-7.

-Adil A, Godwin M. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis. J Am Acad Dermatol. 2017; 77:136-141.

-Zhou Z, Song S, Gao Z, Wu J, Ma J, Cui Y. The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis. Clin Interv Aging. 2019; 14:399-406.

-Kozicka K, Łukasik A, Pastuszczak M, Wojas-Pelc A. Methods of treatment patients with androgenetic alopecia based on reference of Department of Dermatology in Cracow. Pol Merkur Lekarski. 2019; 46:80-83.

–Panchaprateep R, Pisitkun T, Kalpongnukul N. Quantitative proteomic analysis of dermal papilla from male androgenetic alopecia comparing before and after treatment with low-level laser therapy. Lasers Surg Med. 2019. doi: 10.1002/lsm.23074.

-Gentile P, Scioli MG, Bielli A, De Angelis B, De Sio C, De Fazio D, Ceccarelli G, Trivisonno A, Orlandi A, Cervelli V, Garcovich S. Platelet-Rich Plasma and Micrografts Enriched with Autologous Human Follicle Mesenchymal Stem Cells Improve Hair Re-Growth in Androgenetic Alopecia. Biomolecular Pathway Analysis and Clinical Evaluation. Biomedicines. 2019; 7. pii: E27.

-Loh SH, Lew BL, Sim WY. Localized Telogen Effluvium Following Hair Transplantation. Ann Dermatol. 2018; 30:214-217.

–Malkud S. Telogen Effluvium: A Review. J Clin Diagn Res. 2015; 9:WE01-3.

-Speiser JJ, Mondo D, Mehta V, Marcial SA, Kini A, Hutchens KA. Regulatory T-Cells in alopecia areata. J Cutan Pathol. 2019. doi: 10.1111/cup.13479.

-Rajabi F, Amoli MM, Robati RM, Almasi-Nasrabadi M, Jabalameli N, Moravvej H. The Association between Genetic Variation in Wnt Transcription Factor TCF7L2 (TCF4) and Alopecia Areata. Immunol Invest. 2019 23:1-8.

-Lee S, Kim BJ, Lee CH, Lee WS. Topographic Phenotypes of Alopecia Areata and Development of a Prognostic Prediction Model and Grading System: A Cluster Analysis. JAMA Dermatol. 2019. doi: 10.1001/jamadermatol.2018.5894.

-Lyakhovitsky A, Aronovich A, Gilboa S, Baum S, Barzilai A. Alopecia areata: a long-term follow-up study of 104 patients. J Eur Acad Dermatol Venereol. 2019. doi: 10.1111/jdv.15582.

–Lee S, Lee YB, Kim BJ, Lee WS. Screening of thyroid function and autoantibodies in patients with alopecia areata: A systematic review and meta-analysis. J Am Acad Dermatol. 2019; 80:1410-1413.

–Rencz F, Gulácsi L, Péntek M, Wikonkál N, Baji P, Brodszky V. Alopecia areata and health-related quality of life: a systematic review and meta-analysis. Br J Dermatol. 2016; 175:561-71.

-Abal Díaz L, Soria Gili X, Casanova Seuma JM. Tratamiento de las alopecias. FMC – Formación Médica Continuada en Atención Primaria. 2010; 17:698-706.

–Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nature reviews Disease primers. 2017; 3:17011.

–Freire PCB, Petri V, Atallah AN. Minoxidil for Patchy Alopecia Areata: Systematic Review and Meta-Analysis. J Eur Acad Dermatol Venereol. 2019. doi: 10.1111/jdv.15545.

–Wu SZ, Wang S, Ratnaparkhi R, Bergfeld WF. Treatment of pediatric alopecia areata with anthralin: A retrospective study of 37 patients. Pediatr Dermatol. 2018; 35:817-820.

–Lee S, Kim BJ, Lee YB, Lee WS. Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis. JAMA Dermatol. 2018; 154:1145-1151.

–Hosking AM, Juhasz M, Mesinkovska NA. Topical Janus kinase inhibitors: A review of applications in dermatology. J Am Acad Dermatol. 2018; 79:535-544.

-Açıkgöz G, Ozmen I, Cayırlı M, Yeniay Y, Köse O. Pulse methylprednisolone therapy for the treatment of extensive alopecia areata. J Dermatolog Treat. 2014; 25:164-6.

-Yoshimasu T, Kanazawa N, Yamamoto Y, Furukawa F. Multiple courses of pulse corticosteroid therapy for alopecia areata. J Dermatol. 2016; 43:1075-7.

-Jahn-Bassler K, Bauer WM, Karlhofer F, Vossen MG, Stingl G. Sequential high- and low-dose systemic corticosteroid therapy for severe childhood alopecia areata. J Dtsch Dermatol Ges. 2017; 15:42-47.

-Seo J, Lee YI, Hwang S, Zheng Z, Kim DY. Intramuscular triamcinolone acetonide: An undervalued option for refractory alopecia areata. J Dermatol. 2017; 44:173-179.

-Browne R, Stewart L, Williams HC. Is methotrexate an effective and safe treatment for maintaining hair regrowth in people with alopecia totalis? A Critically Appraised Topic. Br J Dermatol. 2018; 179:609-614.

-Fernández JM, Molinero I, Castán E, Casanova JM. Perfiles psicológicos de los pacientes con psicodermatosis. Piel 2016; 31:15-23

-Martín JM, Montesinos E, Cordero P, Gonzalez V, Ramon D. Trichoscopy features of trichotillomania. Pediatr Dermatol. 2019; 36:265-267.

-Sani G, Gualtieri I, Paolini M, Bonanni L, Spinazzola E, Maggiora M, Pinzone V, Brugnoli R, Angeletti G, Girardi P, Rapinesi C, Kotzalidis GD. Drug Treatment Of Trichotillomania (Hair-Pulling Disorder), Excoriation (Skin-Picking) Disorder, And Nail-Biting (Onychophagia). Curr Neuropharmacol. 2019. doi: 10.2174/1570159X17666190320164223.

-Anzai A, Wang EHC, Lee EY, Aoki V, Christiano AM. Pathomechanisms of immune-mediated alopecia. Int Immunol. 2019; 31:439-447.

-Rigopoulos D, Stamatios G, Ioannides D. Primary scarring alopecias. Curr Probl Dermatol. 2015; 47:76-86.

-Abal-Díaz L, Soria X, Casanova-Seuma JM. Alopecias cicatriciales. Actas Dermosifiliogr. 2012; 103:376-87.

-Bolduc C, Sperling LC, Shapiro J. Primary cicatricial alopecia: Lymphocytic primary cicatricial alopecias, including chronic cutaneous lupus erythematosus, lichen planopilaris, frontal fibrosing alopecia, and Graham-Little syndrome. J Am Acad Dermatol. 2016; 75:1081-1099.

-Soares VC, Mulinari-Brenner F, Souza TE. Lichen planopilaris epidemiology: a retrospective study of 80 cases. An Bras Dermatol. 2015; 90:666-70.

-Bulbul Baskan E, Yazici S. Treatment of lichen planopilaris: methotrexate or cyclosporine a therapy? Cutan Ocul Toxicol. 2018; 37:196-199.

-Wagner G, Meyer V, Sachse MM. Frontal fibrosierende Alopezie Kossard. Hautarzt. 2016; 67:891-896.

-Mirmirani P, Tosti A, Goldberg L, Whiting D, Sotoodian B. Frontal Fibrosing Alopecia: An Emerging Epidemic. Skin Appendage Disord. 2019; 5:90-93.

-To D, Beecker J. Frontal Fibrosing Alopecia: Update and Review of Challenges and Successes. J Cutan Med Surg. 2018; 22:182-189.

–Fabbri P, Amato L, Chiarini C, Moretti S, Massi D. Scarring alopecia in discoid lupus erythematosus: a clinical, histopathologic and immunopathologic study. Lupus. 2004; 13:455-62.

-Wilson CL, Burge SM, Dean D, Dawber RP. Scarring alopecia in discoid lupus erythematosus. Wilson Br J Dermatol. 1992; 126:307-14.

-Nascimento LLD, Enokihara MMSES, Vasconcellos MRA. Coexistence of chronic cutaneous lupus erythematosus and frontal fibrosing alopecia. An Bras Dermatol. 2018; 93:274-276.

-Concha JSS, Werth VP. Alopecias in lupus erythematosus. Lupus Sci Med. 2018; 5:e000291.

-Igari S, Yamamoto T. Dramatic effect of hydroxychloroquine on lupus alopecia. J Dermatol. 2018; 45:194-197.

-Otberg N, Kang H, Alzolibani AA, Shapiro J. Folliculitis decalvans. Dermatol Ther. 2008; 21:238-44.

-Matard B, Donay JL, Resche-Rigon M, Tristan A, Farhi D, Rousseau C, Mercier-Delarue S, Cavelier-Balloy B, Assouly P, Petit A, Bagot M, Reygagne P. Folliculitis decalvans is characterized by a persistent, abnormal subepidermal microbiota. Exp Dermatol. 2019. doi: 10.1111/exd.13916.

–Vañó-Galván S, Molina-Ruiz AM, Fernández-Crehuet P, Rodrigues-Barata AR, Arias-Santiago S, Serrano-Falcón C, Martorell-Calatayud A, Barco D, Pérez B, Serrano S, Requena L, Grimalt R, Paoli J, Jaén P, Camacho FM. Folliculitis decalvans: a multicentre review of 82 patients. J Eur Acad Dermatol Venereol. 2015; 29:1750-7.

-Pimenta R, Borges-Costa J. Successful Treatment with Fusidic Acid in a Patient with Folliculitis Decalvans. Acta Dermatovenerol Croat. 2019; 27:49-50.

-Aksoy B, Hapa A, Mutlu E. Isotretinoin treatment for folliculitis decalvans: a retrospective case-series study. Int J Dermatol. 2018; 57:250-253.

–Ogunbiyi A. Acne keloidalis nuchae: prevalence, impact, and management challenges. Clin Cosmet Investig Dermatol. 2016; 9:483-489.

-Na K, Oh SH, Kim SK. Acne keloidalis nuchae in Asian: A single institutional experience. PLoS One. 2017; 12:e0189790.

-East-Innis ADC, Stylianou K, Paolino A, Ho JD. Acne keloidalis nuchae: risk factors and associated disorders – a retrospective study. Int J Dermatol. 2017; 56:828-832.

–Maranda EL, Simmons BJ, Nguyen AH, Lim VM, Keri JE. Treatment of Acne Keloidalis Nuchae: A Systematic Review of the Literature. Dermatol Ther (Heidelb). 2016; 6:363-78.

–de Berker D. Nail anatomy. Clin Dermatol. 2013; 31:509-15.

-Saito M, Ohyama M, Amagai M. Exploring the biology of the nail: An intriguing but less-investigated skin appendage. J Dermatol Sci. 2015; 79:187-93.

–Haneke E. Anatomy of the nail unit and the nail biopsy. Semin Cutan Med Surg. 2015; 34:95-100.

–Perrin C, Michiels JF, Boyer J, Ambrosetti D. Melanocytes Pattern in the Normal Nail, With Special Reference to Nail Bed Melanocytes. Am J Dermatopathol. 2018; 40:180-184.

-Grover C, Jakhar D. Onychoscopy: A practical guide. Indian J Dermatol Venereol Leprol. 2017; 83:536-549.

-Reinig E, Rich P, Thompson CT. How to submit a nail specimen. Dermatol Clin. 2015; 33:303-7.

-Wollina U, Nenoff P, Haroske G, Haenssle HA. The Diagnosis and Treatment of Nail Disorders. Dtsch Arztebl Int. 2016; 113:509-18.

–Ko D, Oromendia C, Scher R, Lipner SR. Retrospective single-center study evaluating clinical and dermoscopic features of longitudinal melanonychia, ABCDEF criteria, and risk of malignancy. J Am Acad Dermatol. 2019;80:1272-1283.

-Duhard É. Les paronychies. Presse Med. 2014; 43:1216-22.

-Heidelbaugh JJ, Lee H. Management of the ingrown toenail. Am Fam Physician. 2009; 79:303-8.

-Ventura A, Mazzeo M, Gaziano R, Galluzzo M, Bianchi L, Campione E. New insight into the pathogenesis of nail psoriasis and overview of treatment strategies. Drug Des Devel Ther. 2017; 11:2527-2535.

-Schons KR, Knob CF, Murussi N, Beber AA, Neumaier W, Monticielo OA. Nail psoriasis: a review of the literature. An Bras Dermatol. 2014; 89:312-7.

-Chiheb S, Haim H, Ouakkadi A, Benchikhi H. Caractéristiques cliniques et évolutives du lichen plan unguéal: étude descriptive de 20 patients. Ann Dermatol Venereol. 2015; 142:21-5.

-Alsenaid A, Eder I, Ruzicka T, Braun-Falco M, Wolf R. Successful treatment of nail lichen planus with alitretinoin: report of 2 cases and review of the literature. Dermatology. 2014; 229:293-6.

–Roest YBM, van Middendorp HT, Evers AWM, van de Kerkhof PCM, Pasch MC. Nail Involvement in Alopecia Areata: A Questionnaire-based Survey on Clinical Signs, Impact on Quality of Life and Review of the Literature. Acta Derm Venereol. 2018; 98:212-217.

-Singal A, Daulatabad D. Nail tic disorders: Manifestations, pathogenesis and management. Indian J Dermatol Venereol Leprol. 2017; 83:19-26.